immun
jird
elicit
partial
protect
challeng
infect
filari
parasit
brugia
malayi
studi
initi
compar
protect
immun
respons
elicit
follow
immun
recombin
protein
regimen
dna
regimen
studi
show
protein
vaccin
confer
approxim
protect
compar
dna
vaccin
confer
protect
analysi
protect
immun
respons
show
protein
immun
promot
respons
increas
respons
wherea
dna
vaccin
promot
respons
profound
respons
sinc
protein
vaccin
gave
better
result
dna
vaccin
want
evalu
whether
primeboost
vaccin
combin
dna
prime
protein
boost
significantli
increas
protect
respons
induc
protein
vaccin
result
suggest
primeboost
vaccin
ad
advantag
compar
less
effect
protect
protein
alon
vaccin
prime
boost
vaccin
gener
mix
respons
slightli
diminish
respons
compar
protein
vaccin
thu
result
suggest
protein
vaccin
regimen
may
slightli
better
primeboost
vaccin
regimen
mechan
protect
appear
larg
mediat
respons
lymphat
filariasi
caus
wuchereria
bancrofti
brugia
malayi
affect
million
peopl
worldwid
caus
major
public
health
problem
especi
tropic
clinic
diseas
classifi
distinct
stage
includ
microfilaraem
mf
individu
asymptomat
microfilaraem
chronic
patholog
cp
individu
clinic
evid
lymphat
obstruct
amicrofilaraem
addit
individu
asymptomat
amicrofilaraem
believ
resist
diseas
design
endem
normal
en
chemotherapi
vector
base
control
measur
wide
employ
mani
endem
region
curti
et
al
fraser
et
al
maxwel
et
al
ramzi
et
al
howev
control
method
limit
util
sever
factor
includ
develop
possibl
drug
pesticid
resist
high
cost
chemotherapi
program
inaccess
mani
year
requir
drug
treatment
infect
popul
poor
region
molyneux
et
al
henc
develop
control
measur
vaccin
would
best
addit
strategi
elimin
filariasi
previou
studi
show
vaccin
recombin
paramyosin
could
offer
partial
protect
larval
challeng
li
et
al
howev
vaccin
studi
use
murray
et
al
heat
shock
protein
myosin
iv
collagen
peralta
et
al
yield
encourag
result
among
recombin
vaccin
candid
analyz
alt
abund
larval
transcript
famili
protein
appear
elicit
significantli
high
protect
respons
b
malayi
gnanasekar
et
al
gregori
et
al
express
protein
start
late
stage
peak
stage
thu
protein
abundantli
synthes
infect
stage
parasit
believ
play
major
role
transmiss
infect
filari
parasit
gregori
et
al
gomezescobar
et
al
interestingli
sera
endem
normal
individu
en
asymptomat
microfilarem
mf
chronic
lymphat
obstructionelephantiasi
chronic
patholog
cp
patient
significantli
high
level
circul
antibodi
gnanasekar
et
al
ramachandran
et
al
sinc
en
subject
consid
put
immun
individu
sever
studi
conduct
evalu
potenti
potenti
vaccin
candid
gnanasekar
et
al
ramachandran
et
al
studi
show
immun
mice
jird
recombin
confer
protect
find
coupl
fact
human
homologu
suggest
may
ideal
candid
vaccin
develop
human
lymphat
filariasi
dna
vaccin
attract
approach
studi
protect
immun
filari
parasit
even
though
dna
vaccin
initi
thought
ideal
vaccin
intracellular
pathogen
gardner
et
al
hoffman
et
al
walker
et
al
recent
find
show
dna
vaccin
could
also
effici
util
vaccin
extracellular
parasit
harrison
bianco
harrison
et
al
kalinna
fact
recent
studi
group
ramachandran
et
al
show
dna
vaccin
code
could
gener
partial
protect
filari
parasit
b
malayi
mous
model
current
variou
strategi
investig
optim
vaccin
infecti
diseas
use
recombin
dna
vaccin
technolog
heterolog
primeboost
vaccin
one
approach
prime
dna
differ
agent
like
recombin
viru
protein
use
boost
dose
obtain
enhanc
protect
efficaci
ferraz
et
al
santra
et
al
vordermei
et
al
wang
et
al
sever
studi
show
strategi
use
dna
prime
immun
system
recombin
protein
boost
immun
respons
could
lead
better
cellular
antibodi
respons
vaccin
anim
compar
homolog
protein
dna
vaccin
regimen
jone
et
al
letvin
et
al
ruitenberg
et
al
present
studi
compar
degre
protect
immun
confer
dna
proteinboost
vaccin
prime
boost
regimen
dna
primedna
boost
dna
vaccin
protein
primeprotein
boost
protein
vaccin
regimen
total
thirti
weekold
male
jird
merion
unguiculatu
use
studi
anim
obtain
mahatma
gandhi
institut
medic
scienc
india
jird
handl
accord
institut
guidelin
approv
institut
anim
care
committe
aed
aegypti
mosquito
infect
feed
b
malayi
microfilaria
jird
blood
twelv
day
infect
b
malayi
larva
obtain
crush
insect
suzuki
seregeg
care
remov
larva
count
microscop
use
challeng
infect
express
vector
prset
b
invitrogen
carlsbad
ca
use
express
recombin
histidin
tag
protein
gnanasekar
et
al
plasmid
transform
escherichia
coli
plyss
express
bacteri
cultur
induc
mm
thiogalactosid
subsequ
incub
h
histidinetag
protein
purifi
pellet
bacteria
use
chelat
sepharos
fast
flow
chromatographi
amersham
bioscienc
uppsala
sweden
per
manufactur
recommend
prior
immun
endotoxin
content
protein
prepar
determin
limulu
amebocyt
lysat
assay
etox
sigma
st
loui
mo
found
less
eumg
express
plasmid
design
construct
insert
gene
vector
ramachandran
et
al
empti
plasmid
use
control
immun
plasmid
maintain
propag
e
coli
cell
subsequ
plasmid
purifi
use
endotoxin
free
plasmid
extract
kit
qiagen
hilden
germani
per
manufactur
instruct
dna
analyz
agaros
gel
electrophoresi
quantifi
spectrophotometri
od
od
ratio
dna
final
dilut
endotoxin
free
phosphat
buffer
salin
pb
dna
detect
level
endotoxin
determin
amebocyt
lysat
assay
sigma
total
thirti
weekold
male
jird
five
group
use
immun
jird
receiv
three
dose
day
fig
show
schemat
represent
vaccin
protocol
use
experi
jird
immun
use
three
differ
regimen
dose
dna
protein
use
studi
select
base
previou
public
gregori
et
al
li
et
al
regimen
use
dna
vaccin
protocol
regimen
use
intramuscularli
im
dna
prime
amount
dna
boost
regimen
use
protein
vaccin
protocol
regimen
jird
prime
alum
adsorb
protein
given
intraperiton
ip
boost
amount
protein
ip
regimen
use
primeboost
vaccin
protocol
regimen
jird
immun
two
dose
dna
given
im
day
respect
booster
dose
consist
alum
adsorb
given
ip
day
two
group
jird
repres
control
group
receiv
either
blank
vector
dna
im
alumpb
ip
vaccineinduc
protect
evalu
day
first
immun
use
micropor
chamber
method
fig
immun
anim
challeng
use
micropor
chamber
techniqu
describ
elsewher
abraham
et
al
lang
et
al
micropor
chamber
consist
plexigla
ring
cover
polycarbon
membran
millipor
corpor
bedford
cyanoacryl
adhes
use
bind
membran
ring
chamber
steril
h
parasit
challeng
infect
suspend
medium
supplement
heat
inactiv
fetal
calf
serum
fc
inocul
chamber
chamber
seal
mf
cement
millipor
chamber
implant
peritoneum
jird
anesthesia
day
post
immun
asept
condit
follow
surgic
procedur
skin
sutur
anim
allow
recov
h
implant
ie
day
immun
anim
sacrif
chamber
recov
peritoneum
content
chamber
examin
microscop
cell
adher
death
parasit
parasit
consid
dead
motil
sever
adher
cell
surfac
percentag
protect
calcul
use
follow
formula
number
dead
larva
number
larva
place
micropor
chamber
sera
collect
immun
jird
day
post
immun
fig
titer
antibodi
sera
analyz
elisa
describ
previous
gnanasekar
et
al
ramachandran
et
al
minor
modif
briefli
well
well
microtit
plate
coat
ng
recombin
protein
suspend
coat
buffer
nahco
na
co
ph
incub
overnight
wash
pbst
pb
contain
triton
bsa
ad
per
well
block
nonspecif
site
incub
h
wash
pbst
serial
dilut
jird
sera
ad
incub
h
determin
isotyp
antibodi
goat
antimous
ad
incub
h
well
wash
pbst
alkalin
phosphatas
label
goat
antimous
igg
sigma
ad
incub
hour
color
develop
use
pnitrophenyl
phosphat
substrat
mgml
substrat
buffer
mm
triscl
ph
mm
nacl
mm
mgcl
n
naoh
ad
well
stop
reaction
absorb
measur
nm
micropl
reader
singl
cell
suspens
spleen
cell
prepar
immun
control
jird
day
post
immun
approxim
cell
per
well
suspend
one
ml
supplement
heat
inactiv
fc
gentamicin
glutamin
hepe
cultur
sixwel
plate
cell
cultur
triplic
well
stimul
protein
cultur
medium
alon
plate
incub
co
incub
day
hthymidin
per
well
amersham
bioscienc
ad
well
incub
cell
harvest
h
later
hthymidin
uptak
measur
liquid
scintil
counter
express
stimul
index
si
count
per
min
stimul
culturescount
per
min
unstimul
cultur
jird
cytokin
mrna
cell
pellet
analyz
rtpcr
briefli
spleen
cell
immun
control
jird
cultur
concentr
cellsml
sixwel
plate
presenc
antigen
day
cultur
cell
centrifug
rpm
min
supernat
discard
cell
cultur
media
alon
serv
control
total
rna
extract
cell
pellet
use
trizol
reagent
gibco
brl
life
technolog
carlsbad
ca
accord
manufactur
instruct
follow
prepar
subsequ
wash
ethanol
rna
pellet
dissolv
diethylpyrocarbon
sigma
treat
water
treatment
dnase
total
rna
quantifi
use
spectrophotomet
nm
qualiti
rna
determin
ratio
optic
densiti
nm
nm
revers
transcript
total
rna
perform
use
protoscript
first
strand
cdna
synthesi
kit
new
england
biolab
beverli
per
manufactur
recommend
cdna
subject
pcr
use
primer
jird
tabl
use
intern
control
pcr
perform
use
minicycl
mj
research
usa
first
step
consist
denatur
min
follow
cycl
consist
min
denatur
step
min
anneal
step
extens
final
extens
min
pcr
amplif
cycl
carri
ensur
product
lie
within
linear
portion
curv
pcr
product
visual
electrophoresi
agaros
gel
contain
ethidium
bromid
gel
scan
determin
band
intens
pcr
product
densitometri
valu
cytokin
mrna
express
percentag
mean
intens
group
ausiello
et
al
ausiello
et
al
mannwhitney
u
test
appli
analyz
data
vaccin
studi
probabl
valu
p
consid
statist
signific
sera
collect
day
ie
day
final
booster
dose
determin
antibodi
titer
control
group
anim
detect
specif
antibodi
sera
contrast
anim
immun
protein
dna
primeboost
vaccin
show
specif
antibodi
sera
fig
primeboost
vaccin
regimen
induc
significantli
higher
titer
antibodi
compar
dna
vaccin
alon
p
protein
vaccin
induc
highest
level
specif
igg
titer
also
investig
isotyp
antibodi
gener
follow
variou
immun
regimen
determin
whether
correl
protect
one
group
immunoglobulin
isotyp
furthermor
antibodi
isotyp
also
offer
good
surrog
marker
immun
respons
rizzo
et
al
level
correl
level
correl
thu
could
also
determin
relationship
respons
follow
variou
immun
regimen
calcul
ratio
fig
increas
ratio
suggest
respons
wherea
revers
ratio
suggest
respons
anim
vaccin
protein
alon
high
ratio
suggest
respons
wherea
anim
immun
dna
alon
low
ratio
suggest
respons
interestingli
howev
primeboost
vaccin
anim
high
ratio
compar
protein
vaccin
anim
find
suggest
immun
protein
even
booster
dose
increas
titer
dna
prime
anim
push
respons
pathway
determin
cellular
immun
respons
spleen
cell
cultur
presenc
protein
prolif
respons
cytokin
profil
evalu
shown
fig
spleen
cell
anim
immun
protein
dna
primeboost
vaccin
show
signific
prolif
respons
antigen
p
wherea
prolif
respons
cell
control
group
near
background
level
cell
primeboost
vaccin
group
show
signific
prolif
respons
antigen
compar
dna
vaccin
group
p
interestingli
cell
protein
vaccin
group
show
significantli
higher
cell
prolifer
respons
primeboost
vaccin
group
p
sinc
cell
prolifer
significantli
recombin
antigen
cytokin
profil
prolifer
cell
investig
rtpcr
use
determin
messag
level
cytokin
valu
express
percentag
increas
mean
intens
product
group
fig
summar
mrna
express
spleen
cell
stimul
antigen
spleen
cell
control
group
show
detect
cytokin
express
messag
level
stimul
protein
data
shown
spleen
cell
collect
anim
immun
protein
vaccin
alon
promin
mrna
express
wherea
spleen
cell
jird
immun
dna
vaccin
express
high
level
compar
thu
clear
dichotomi
cytokin
respons
anim
vaccin
protein
dna
howev
dna
prime
anim
boost
protein
increas
express
mrna
thu
singl
booster
inject
protein
primeboost
vaccin
regimen
suffici
induc
robust
respons
environ
gener
dna
prime
dose
micropor
chamber
implant
periton
caviti
immun
jird
day
post
immun
week
final
booster
dose
h
implant
micropor
chamber
harvest
percent
dead
worm
determin
use
micropor
chamber
significantli
allevi
problem
recov
parasit
periton
caviti
allow
us
count
exact
number
larval
death
microscop
examin
worm
recov
micropor
chamber
reveal
larg
number
macrophag
polymorph
nuclear
cell
adher
dead
larva
number
dead
live
larva
within
micropor
chamber
count
percent
protect
calcul
result
show
immun
dna
alon
could
induc
protect
vaccin
anim
tabl
comparison
protect
efficaci
protein
vaccin
primeboost
vaccin
regimen
show
protein
vaccin
alon
enough
elicit
maximum
protect
level
jird
immun
primeboost
vaccin
less
live
larva
significantli
less
anim
immun
dna
vaccin
alon
p
thu
protect
could
achiev
primeboost
vaccin
interestingli
immun
protein
alon
equal
effect
elicit
signific
larval
kill
respons
induc
protect
p
present
studi
compar
protect
efficaci
primeboost
dna
prime
follow
protein
boost
vaccin
dna
vaccin
regimen
alon
recombin
protein
vaccin
alon
jird
model
b
malayi
result
show
protein
vaccin
much
superior
dna
vaccin
alon
primeboost
vaccin
analysi
antibodi
cytokin
respons
suggest
immun
respons
predomin
protein
vaccin
filariai
recogn
one
major
poverti
promot
diseas
tropic
countri
hotez
ferri
effect
vaccin
would
serv
valuabl
addit
exist
control
measur
advanc
effort
elimin
diseas
reduct
poverti
sever
effort
made
develop
protect
vaccin
filariasi
li
et
al
gregori
et
al
effort
focuss
potenti
vaccin
candid
use
phagedisplay
base
immuno
screen
analysi
recent
demonstr
potenti
candid
vaccin
antigen
gnanasekar
et
al
subsequ
studi
show
given
protein
vaccin
alon
gave
better
result
dna
vaccin
alon
mous
model
ramachandran
et
al
therefor
studi
evalu
whether
dna
primeprotein
boost
vaccin
ad
advantag
protein
vaccin
alon
sever
import
characterist
vaccin
candid
includ
high
level
express
infect
larval
stage
present
abund
target
immun
system
importantli
known
homolog
mammalian
speci
fact
perviou
studi
use
protein
vaccin
candid
antigen
gave
promis
result
anim
model
one
studi
also
use
adult
worm
establish
read
vaccineinduc
protect
immunis
jird
gnanasekar
et
al
studi
show
vaccin
protein
could
induc
protect
similar
result
observ
present
studi
use
accur
micropor
chamber
approach
confirm
previou
observ
excel
vaccin
candid
encourag
success
recombin
protein
vaccin
effort
subsequ
initi
develop
dna
vaccin
dnabas
vaccin
attempt
vari
success
use
vaccin
candid
lymphat
filariasi
exampl
vaccin
studi
use
paramyosin
dna
confer
signific
protect
li
et
al
howev
one
previou
studi
suggest
dna
vaccin
could
induc
partial
protect
mice
model
b
malayi
infect
ramachandran
et
al
repeat
similar
studi
jird
permiss
host
result
also
confirm
dna
vaccin
could
confer
signific
less
protect
compar
protein
vaccin
recent
develop
vaccin
research
suggest
heterolog
primeboost
protocol
advantag
homolog
primeboost
protocol
jone
et
al
letvin
et
al
ruitenberg
et
al
vordermei
et
al
wang
et
al
present
work
analyz
whether
similar
approach
could
use
improv
protect
effect
dna
protein
vaccin
expect
result
show
primeboost
vaccin
regimen
confer
significantli
enhanc
protect
b
malayi
infect
compar
dna
vaccin
alon
nevertheless
protect
respons
induc
primeboost
vaccin
effect
protein
vaccin
alon
analysi
characterist
protect
immun
respons
show
primeboost
vaccin
anim
high
ratio
sera
suggest
bias
respons
howev
truli
reflect
antigenspecif
cytokin
profil
evalu
rtpcr
cell
anim
stimul
recombin
protein
nearli
equal
amount
produc
suggest
type
respons
may
import
primeboost
mediat
protect
respons
similar
discrep
isotyp
cytokin
report
previous
macdonald
et
al
analysi
igg
isotyp
cytokin
profil
vaccin
anim
reveal
immun
alumadsorb
protein
vaccin
promot
type
immun
respons
evidenc
increas
serum
level
high
ratio
bia
might
also
partial
due
alum
prepar
well
establish
alum
adjuv
preferenti
stimul
immun
respons
brewer
et
al
earlier
studi
show
respons
associ
protect
immun
respons
variou
nematod
parasit
babu
et
al
le
goff
et
al
martin
et
al
volkmann
et
al
role
cytokin
suggest
protect
respons
present
studi
also
observ
increas
mrna
express
anim
immun
protein
vaccin
increas
respons
seen
anim
immun
dna
vaccin
alon
howev
primeboost
vaccin
anim
increas
suggest
respons
might
mediat
protein
boost
previou
studi
also
suggest
may
essenti
vaccinemedi
protect
filari
infect
mice
le
increas
express
protein
vaccin
anim
suggest
mediat
respons
may
also
role
jird
permiss
host
dna
vaccin
predominantli
gener
respons
evidenc
high
level
decreas
ratio
high
respons
slightli
diminish
primeboost
vaccin
fact
primeboost
vaccin
anim
show
mix
respons
dna
compon
primeboost
regimen
probabl
respons
respons
protein
compon
primeboost
regimen
respons
increas
level
specif
serum
antibodi
nevertheless
respons
suffici
enough
regul
induc
dna
vaccin
primeboost
regimen
strong
respons
protein
primeboost
vaccin
anim
suggest
antibodi
may
signific
role
vaccineinduc
protect
focu
present
studi
character
role
antibodi
howev
passiv
transfer
experi
use
variou
isotyp
antibodi
would
use
determin
role
isotyp
antibodi
especi
vaccineinduc
immun
conclus
studi
show
vaccin
use
alum
adsorb
vaccin
superior
induc
protect
respons
b
malayi
jird
compar
dna
alon
dna
prime
proteinboost
vaccin
regimen
analysi
antibodi
cytokin
respons
suggest
respons
may
import
protect
induc
protein
studi
enhanc
respons
induc
protein
vaccin
drive
adjuv
might
enhanc
protect
effect
schemat
represent
immun
protocol
use
studi
specif
igg
titer
jird
immun
differ
protocol
jird
bled
day
last
immun
igg
titer
detect
elisa
optic
densiti
measur
nm
antibodi
titer
defin
reciproc
dilut
sera
yield
onehalf
maxim
absorb
nm
data
repres
mean
titer
logarithm
scale
standard
error
group
anim
ratio
titer
titer
differ
group
ratio
obtain
divid
titer
data
present
mean
box
sd
valu
lymphocyt
prolif
respons
spleen
cell
collect
immun
anim
stimul
data
shown
mean
standard
deviat
stimul
index
cytokin
mrna
level
spleen
cell
stimul
protein
h
cytokin
mrna
express
analyz
rtpcr
actual
densitometr
valu
cytokin
mrna
normal
use
densitometri
refer
valu
express
percentag
